Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation

Dan Liu1, Xiao-Xue Zhang1, Meng-Chen Li1

  • 1Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.

Nature Communications
|May 2, 2018
PubMed

Insights

Chemoresistance in ovarian cancer is linked to epigenetic changes. Transcription factor C/EBPβ recruits DOT1L to methylate drug-resistance genes, promoting chemoresistance and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Chemoresistance presents a significant challenge in ovarian cancer treatment.
  • Epigenetic modifications are crucial in regulating cancer cell behavior and drug resistance.

Purpose of the Study:

  • To investigate the role of transcription factors in mediating epigenetic modifications related to chemoresistance in ovarian cancer.
  • To identify potential therapeutic targets within epigenetic regulatory pathways.

Main Methods:

  • Analysis of transcription factors (C/EBPβ, GCM1, GATA1) as modulators of histone methylation.
  • Investigating the mechanism of C/EBPβ in recruiting DOT1L (a methyltransferase).
  • Assessing the impact of H3K79 methylation on drug-resistance genes and chemoresistance.

Main Results:

  • Identified C/EBPβ, GCM1, and GATA1 as potential regulators of histone methylation in ovarian cancer cells.
  • C/EBPβ acts as an independent prognostic factor in ovarian cancer.
  • C/EBPβ recruits DOT1L to facilitate H3K79 methylation of drug-resistance genes, enhancing chemoresistance.

Conclusions:

  • C/EBPβ plays a critical role in maintaining chemoresistance through epigenetic regulation of drug-resistance genes.
  • Targeting key epigenetic regulators like C/EBPβ offers a promising strategy for overcoming chemoresistance in ovarian cancer.
  • This research proposes novel epigenetic therapeutic avenues for ovarian cancer treatment.

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

14.3K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.8K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.1K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K